Ado-Trastuzumab Emtansine in Metastatic HER2-Positive Breast Cancer
Rena Callahan, MD
From UCLA Medical Center, Hematology Oncology, Los Angeles, California
Author's disclosures of potential conflicts of interest are found at the end of this article.
Correspondence to: Rena Callahan, MD, UCLA Medical Center, Hematology Oncology, 10833 LeConte Blvd, 100 UCLA Medical Plaza Suite 550, Los Angeles, CA 90095.
J Adv Pract Oncol 2014;5:134-139 |
DOI: 10.6004/jadpro.2014.5.2.5 |
© 2014 Harborside Press®
For access to the full length article, please sign in